This is a proposal to understand Ah receptor (AHR) biology and also an attempt to develop new tools for the toxicologist. In this proposal, we will couple recombinant mouse models, liver cell isolation techniques and modern genomic technology to identify those transcriptional outputs that define the AHR's role in the hepatotoxic effects of potent agonists like 2,3,7,8-tetrachlorodibenzo-pdioxin (""""""""dioxin""""""""). In parallel, we will use the AHR as a model system to develop a new generation of tools, reagents and resources that will aid biologists in their efforts to understand toxicant action.
Our specific aims are:
Aim 1 : Develop cDNA clone sets and microarray technologies (MAT) that are optimal for the study of AHR signaling in parenchymal and nonparenchymal cell types.
Aim 2 : Develop statistical tools for the optimal design of toxicogenomics studies, as well as to interpret these studies by incorporating data from mutant animal models, pathology and the biomedical literature.
Aim 3 : We will test the hypothesis that various cell types are interacting and that this interaction can be detected through the presentation of waves of temporally linked transcriptional change.
Aim 4 : Elucidate the roles of the candidate genes, AHR, Cyplal, Cypla2, Cyplbl, TNF-a and IL6. Using recombinant mouse models, each of these genes will be tested for roles in aspects of hepatotoxicity or for roles in dioxin-induced signaling across hepatic cell types.
Aim 5 : Test the idea that global aberrations in gene expression can serve as a new definition of toxicity. We will also test the idea that patterns of gene expression will define various pathologies.
Aim 6 : The MAT we develop will have significant application across toxicant classes. Therefore, we will develop a resource where toxicologists can view the transcriptional responses to dioxin and classic hepatotoxicants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES012752-03
Application #
6986184
Study Section
Special Emphasis Panel (ZRG1-GMA-3 (03))
Program Officer
Shreffler, Carol K
Project Start
2004-01-19
Project End
2008-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
3
Fiscal Year
2006
Total Cost
$352,878
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Chernoff, N; Rogers, E H; Zehr, R D et al. (2011) Toxicity and recovery in the pregnant mouse after gestational exposure to the cyanobacterial toxin, cylindrospermopsin. J Appl Toxicol 31:242-54
Vollrath, Aaron L; Smith, Adam A; Craven, Mark et al. (2009) EDGE(3): a web-based solution for management and analysis of Agilent two color microarray experiments. BMC Bioinformatics 10:280
Smith, Adam A; Vollrath, Aaron; Bradfield, Christopher A et al. (2009) Clustered alignments of gene-expression time series data. Bioinformatics 25:i119-27
Smith, Adam A; Craven, Mark (2008) Fast multisegment alignments for temporal expression profiles. Comput Syst Bioinformatics Conf 7:315-26
Smith, Adam A; Vollrath, Aaron; Bradfield, Christopher A et al. (2008) Similarity queries for temporal toxicogenomic expression profiles. PLoS Comput Biol 4:e1000116
Hayes, Kevin R; Zastrow, Gina M; Nukaya, Manabu et al. (2007) Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem Res Toxicol 20:1573-81
Pande, Kalyan; Moran, Susan M; Bradfield, Christopher A (2005) Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines. Mol Pharmacol 67:1393-8
Hayes, Kevin R; Bradfield, Christopher A (2005) Advances in toxicogenomics. Chem Res Toxicol 18:403-14
Hayes, Kevin R; Vollrath, Aaron L; Zastrow, Gina M et al. (2005) EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Mol Pharmacol 67:1360-8